Sign in

Filings

Finds words inside filing documents. Searching Jasper Therapeutics, Inc.'s filings · 64 documents indexed.

11 documents · 77 matches

  1. JSPR Jasper Therapeutics, Inc. 10-Q 2026-08-14

    Item 1 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    11 matches in this document
  2. JSPR Jasper Therapeutics, Inc. 10-Q 2026-05-14

    Item 1 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    11 matches in this document
  3. JSPR Jasper Therapeutics, Inc. 10-K 2026-03-30

    Item 8 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    15 matches in this document
  4. JSPR Jasper Therapeutics, Inc. 10-Q 2025-11-10

    Item 1 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    9 matches in this document
  5. JSPR Jasper Therapeutics, Inc. 10-Q 2025-08-13

    Item 1 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    8 matches in this document
  6. JSPR Jasper Therapeutics, Inc. 10-Q 2025-05-12

    Item 1 · Note 2. Summary of Significant Accounting Policies

    Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about
    8 matches in this document
  7. JSPR Jasper Therapeutics, Inc. 8-K/A 2026-10-01

    going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred losses since inception and has an accumulated
    8 matches in this document
  8. JSPR Jasper Therapeutics, Inc. 8-K/A 2026-10-01

    1. Nature of Business, Basis of Presentation and Going Concern
    4 matches in this document
  9. JSPR Jasper Therapeutics, Inc. 8-K 2026-06-01

    going concern and its imminent need to raise additional funding to continue its operations; risks related to Jasper’s ability
    1 match in this document
  10. JSPR Jasper Therapeutics, Inc. 8-K 2026-05-14

    going concern and its imminent need to raise additional funding to continue its operations; the risk that Jasper may be unable
    1 match in this document
  11. JSPR Jasper Therapeutics, Inc. 8-K 2026-03-30

    going concern and the risk that Jasper may be unable to raise capital to continue its operations and continue its Phase
    1 match in this document

Page 1 of 1 · 11 documents